Cargando…
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
INTRODUCTION: Next-generation sequencing (NGS) is currently widely used for biomarker studies and molecular profiling to identify concurrent alterations that can lead to the better characterization of a tumor’s molecular landscape. However, further evaluation of technical aspects related to the dete...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623306/ https://www.ncbi.nlm.nih.gov/pubmed/37927472 http://dx.doi.org/10.3389/fonc.2023.1225646 |
_version_ | 1785130713746505728 |
---|---|
author | Clavé, Sergi Jackson, Jennifer B. Salido, Marta Kames, Jacob Gerding, Kelly M. R. Verner, Ellen L. Kong, Eric F. Weingartner, Elizabeth Gibert, Joan Hardy-Werbin, Max Rocha, Pedro Riera, Xènia Torres, Erica Hernandez, James Cerqueira, Gustavo Nichol, Donna Simmons, John Taus, Álvaro Pijuan, Lara Bellosillo, Beatriz Arriola, Edurne |
author_facet | Clavé, Sergi Jackson, Jennifer B. Salido, Marta Kames, Jacob Gerding, Kelly M. R. Verner, Ellen L. Kong, Eric F. Weingartner, Elizabeth Gibert, Joan Hardy-Werbin, Max Rocha, Pedro Riera, Xènia Torres, Erica Hernandez, James Cerqueira, Gustavo Nichol, Donna Simmons, John Taus, Álvaro Pijuan, Lara Bellosillo, Beatriz Arriola, Edurne |
author_sort | Clavé, Sergi |
collection | PubMed |
description | INTRODUCTION: Next-generation sequencing (NGS) is currently widely used for biomarker studies and molecular profiling to identify concurrent alterations that can lead to the better characterization of a tumor’s molecular landscape. However, further evaluation of technical aspects related to the detection of gene rearrangements and copy number alterations is warranted. METHODS: There were 12 ALK rearrangement-positive tumor specimens from patients with non-small cell lung cancer (NSCLC) previously detected via fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and an RNA-based NGS assay, and 26 MET high gene copy number (GCN) cases detected by FISH, selected for this retrospective study. All 38 pre-characterized cases were reassessed utilizing the PGDx™ elio™ tissue complete assay, a 505 gene targeted NGS panel, to evaluate concordance with these conventional diagnostic techniques. RESULTS: The detection of ALK rearrangements using the DNA-based NGS assay demonstrated excellent sensitivity with the added benefit of characterizing gene fusion partners and genomic breakpoints. MET copy number alterations were also detected; however, some discordances were observed likely attributed to differences in algorithm, reporting thresholds and gene copy number state. TMB was also assessed by the assay and correlated to the presence of NSCLC driver alterations and was found to be significantly lower in cases with NGS-confirmed canonical driver mutations compared with those without (p=0.0019). DISCUSSION: Overall, this study validates NGS as an accurate approach for detecting structural variants while also highlighting the need for further optimization to enable harmonization across methodologies for amplifications. |
format | Online Article Text |
id | pubmed-10623306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106233062023-11-04 Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer Clavé, Sergi Jackson, Jennifer B. Salido, Marta Kames, Jacob Gerding, Kelly M. R. Verner, Ellen L. Kong, Eric F. Weingartner, Elizabeth Gibert, Joan Hardy-Werbin, Max Rocha, Pedro Riera, Xènia Torres, Erica Hernandez, James Cerqueira, Gustavo Nichol, Donna Simmons, John Taus, Álvaro Pijuan, Lara Bellosillo, Beatriz Arriola, Edurne Front Oncol Oncology INTRODUCTION: Next-generation sequencing (NGS) is currently widely used for biomarker studies and molecular profiling to identify concurrent alterations that can lead to the better characterization of a tumor’s molecular landscape. However, further evaluation of technical aspects related to the detection of gene rearrangements and copy number alterations is warranted. METHODS: There were 12 ALK rearrangement-positive tumor specimens from patients with non-small cell lung cancer (NSCLC) previously detected via fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and an RNA-based NGS assay, and 26 MET high gene copy number (GCN) cases detected by FISH, selected for this retrospective study. All 38 pre-characterized cases were reassessed utilizing the PGDx™ elio™ tissue complete assay, a 505 gene targeted NGS panel, to evaluate concordance with these conventional diagnostic techniques. RESULTS: The detection of ALK rearrangements using the DNA-based NGS assay demonstrated excellent sensitivity with the added benefit of characterizing gene fusion partners and genomic breakpoints. MET copy number alterations were also detected; however, some discordances were observed likely attributed to differences in algorithm, reporting thresholds and gene copy number state. TMB was also assessed by the assay and correlated to the presence of NSCLC driver alterations and was found to be significantly lower in cases with NGS-confirmed canonical driver mutations compared with those without (p=0.0019). DISCUSSION: Overall, this study validates NGS as an accurate approach for detecting structural variants while also highlighting the need for further optimization to enable harmonization across methodologies for amplifications. Frontiers Media S.A. 2023-10-20 /pmc/articles/PMC10623306/ /pubmed/37927472 http://dx.doi.org/10.3389/fonc.2023.1225646 Text en Copyright © 2023 Clavé, Jackson, Salido, Kames, Gerding, Verner, Kong, Weingartner, Gibert, Hardy-Werbin, Rocha, Riera, Torres, Hernandez, Cerqueira, Nichol, Simmons, Taus, Pijuan, Bellosillo and Arriola https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Clavé, Sergi Jackson, Jennifer B. Salido, Marta Kames, Jacob Gerding, Kelly M. R. Verner, Ellen L. Kong, Eric F. Weingartner, Elizabeth Gibert, Joan Hardy-Werbin, Max Rocha, Pedro Riera, Xènia Torres, Erica Hernandez, James Cerqueira, Gustavo Nichol, Donna Simmons, John Taus, Álvaro Pijuan, Lara Bellosillo, Beatriz Arriola, Edurne Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title | Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title_full | Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title_fullStr | Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title_full_unstemmed | Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title_short | Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer |
title_sort | comprehensive ngs profiling to enable detection of alk gene rearrangements and met amplifications in non-small cell lung cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623306/ https://www.ncbi.nlm.nih.gov/pubmed/37927472 http://dx.doi.org/10.3389/fonc.2023.1225646 |
work_keys_str_mv | AT clavesergi comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT jacksonjenniferb comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT salidomarta comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT kamesjacob comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT gerdingkellymr comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT vernerellenl comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT kongericf comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT weingartnerelizabeth comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT gibertjoan comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT hardywerbinmax comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT rochapedro comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT rieraxenia comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT torreserica comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT hernandezjames comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT cerqueiragustavo comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT nicholdonna comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT simmonsjohn comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT tausalvaro comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT pijuanlara comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT bellosillobeatriz comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer AT arriolaedurne comprehensivengsprofilingtoenabledetectionofalkgenerearrangementsandmetamplificationsinnonsmallcelllungcancer |